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Resumo 
 
A celulose é o polissacarídeo mais abundante na terra, e é o principal constituinte das 
paredes celulares das plantas. Contudo, também é produzida por bactérias numa forma 
mais pura chamada “celulosa bacteriana” (BC). A BC é já bem conhecida e é utilizada em 
vários campos principalmente devido à sua estrutura 3D que lhe confere excelentes 
propriedades, nomeadamente elevada capacidade de retenção de água, elevada porosidade 
e excelente desempenho mecânico. A BC é também, biodegradável e, biocompatível. Em 
termos de aplicações, a BC é amplamente usada na área biomédica na forma pura ou de 
nanocompósitos como vaso sanguíneos artificiais, sistemas para libertação controlada de 
fármacos e na engenharia de tecidos, etc. 
Este trabalho relata o desenvolvimento de novos nanocompósitos de celulose bacteriana e 
poli(N-metacriliol glicina) preparados por polimerização radicalar in situ usando N,N-
methylenebis(acrylamide) (MBA) como agente reticulante. Foram preparados e 
caracterizados vários nanocompósitos com quantidades variáveis de polímero e BC. Os 
materiais nanocompósitos obtidos apresentaram propriedades mecânicas e térmicas 
melhoradas assim como valores de cristalinidade superiores quando comparados com o 
polímero puro. A citotoxicidade (teste MTT) dos nanocompósitos em relação às celulas da 
pele (HaCaT) foi também avaliada e os resultados demonstraram que as membranas não 
são citotóxicas até 48 horas de exposição. Finalmente, foram testadas duas potenciais 
aplicações para os materiais obtidos, nomeadamente como sistemas de libertação de 
fármacos e como suportes para a regeneração óssea. Neste sentido, as membranas foram 
impregnadas com um fármaco, o diclofenac, e estudada a sua dissolução em condições de 
pH diferentes (pH 7.4 e 2.1) a 37 ºC durante 24h. No entanto, verificou-se que durante a 
libertação do fármaco ocorreu também a dissolução do polímero. Em segundo lugar, as 
membranas foram biomineralizadas com o objectivo de crescer partículas de hidroxiapatite 
na sua superfície para potencial aplicação na regeneração óssea. Contudo, o crescimento 
destas nanopatículas não foi confirmado por XRD e SEM. 
VI 
 
   
Keywords 
 
Bacterial cellulose, poly(N-methacryloyl glycine), nanocomposites, in situ polymerization, drug 
delivery, biomineralization 
Abstract 
 
Cellulose is the most abundant polysaccharide on earth, it is the main structural component 
of plant cell walls. However, it is also produced by bacteria in a purer form called bacterial 
cellulose (BC). BC is well known and mainly used in several field for its peculiar 3D 
network that confers to it outstanding properties such as water high holding capacity, high 
porosity and excellent mechanical properties. BC is also biodegradable and biocompatible. 
Among the different fields of application, BC is greatly used, in its pure form or in the 
form of nanocomposites, in the biomedical field, as artificial blood vessels, controlled drug 
delivery systems, and in tissue engineering, etc. 
The present study reports the development of new nanocomposites made from BC and an 
acrylate polymer namely the poly(N-methacryloyl glycine) (PMGly) through an in situ free 
radical polymerization using N,N-methylenebis(acrylamide) (MBA) as cross linker agent. 
Several nanocomposites with different amounts of polymer and BC were prepared and 
characterized. The obtained nanocomposites displayed improved mechanical properties, 
thermal stability and crystallinity when compared to the homopolymer. Moreover, their 
cytotoxicity (MTT tests) in regard to HaCaT skin cells was also evaluated, and the results 
showed that the new nanocomposites were not cytotoxic until 48 hours of exposure. 
Finally, two different potential applications were tested for these materials, namely as 
systems for drug release and as scaffolds for bone regeneration. First, the membranes were 
tested as drug delivery system for diclofenac. The impregnation of the drug into the 
membrane was successfully assessed and the drug dissolution was studied for different pH 
values (pH 7.4 and 2.1) at 37 ºC during 24 hours. However, the drug release was always 
accompanied by polymer dissolution. Secondly, the membranes were immersed in a 
simulated body solution in order to grow hydroxyapatite particles on their surface, aiming 
an application in bone tissue engineering. However, this growth wasn’t detected by XRD 
and SEM analysis. 
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1. The context 
At the time where high interest is devoted to the development of new technologies and materials 
in order to improve life quality, novel high performance health care products are one of the most 
important focus of scientists. Specifically, advanced medical textiles and devices are topics of 
large interest and fast development due to their importance in different fields such as wound 
healing, implantable medical devices, bandaging, surgery, controlled drug delivery, etc. On the 
other hand, increasing attention and huge efforts have been dedicated to the creation of new 
environmentally friendly and sustainable materials. 
In this context, the present thesis will focus on the development and the characterization of 
novel bacterial cellulose (BC) based nanocomposites prepared by the in situ free radical 
polymerization of adequate monomers for potential application in the biomedical field, for 
example as drug delivery systems or for bone tissue engineering. 
Several studies have shown the potentiality to prepare innovative bio-based nanocomposites 
with distinct properties by combining bacterial cellulose with different natural or synthetic 
polymers using diverse methodologies. Indeed, BC is known for its peculiar 3D structure that 
confers to it high mechanical properties and high water retention ability and is also used in 
several medical fields due to its non-cytotoxicity and biodegradability. Additionally, the 
selection of the polymer and the corresponding methodology used to perform the 
polymerization strongly influence the final properties of the nanocomposites. In this study, the 
aim is to create a new bacterial cellulose based nanocomposite by combination with an acrylate 
polymer with amino-acid like moieties, namely poly(N-methacryloyl glycine), by means of in 
situ free radical polymerization of N-methacryloyl glycine. This new material is expected to 
present improved mechanical properties and biological activity as biocompatibility. In a final 
instance, the objective of this work is to use this novel nanocomposite for biomedical 
applications such as for instance drug delivery, or for bone tissue engineering, therefore the 
possibility to induce biological activity to the BC membranes is very pertinent.  
The present manuscript will be divided into four main parts. An introduction, describing BC’s 
production, properties and main applications, followed by a brief review of BC /polymer 
nanocomposites, with particular emphasis on nanocomposites prepared by in situ 
polymerization approaches. The second part will described the material and methods involved 
in the synthesis and characterisation of the new nanocomposites, as well as in the assessment of 
the future potential applications of the nanocomposites. It will, finally, be followed by a chapter 
describing the obtained results and the main conclusions of the work.  
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2. Introduction 
Cellulose is the most abundant biopolymer on earth and was discovered in 1838 by Anselm 
Payen. This biopolymer is the main component of plant cell walls but it can be also produced by 
several other organisms, including algae, plankton and bacteria.[1] It can be also produced 
through enzymatic and chemical methods.[2] 
From a chemical point of view, cellulose is a polysaccharide composed of glucose units linked 
by β(1-4) glycosidic bonds.[3] It is this type of chemical bonding that confers to cellulose its 
linear structure. The repeating unit of a cellulose chain is represented in Figure 1. 
 
 
Figure 1 - Cellulose repeating unit. 
 
Plant cellulose is typically associated with other plant cell wall constituents, such as 
hemicelluloses, pectins and lignin, and is characterized by a fibrillar structure, composed of 
crystalline and amorphous regions, resulting from the high tendency of cellulose chains to 
establish intra- and intermolecular hydrogen bonds (Figure 2) that promote their aggregation. 
Those hydrogen bonds are also responsible for the high mechanical strength, high crystallinity 
degree of cellulose [4] and insolubility in most common solvents. 
 
 
Figure 2 - Cellulose chains with the hydrogen bondings. [4] 
 
As shown in the Figure 3, cellulose fibers are composed of macrofibers, themselves composed 
of bundles of microfibers; that are aggregates of several cellulose chains. Plant cellulose 
macrofibers can vary from 5 to 30 μm in diameter and approximately from 1 to 25 mm in 
length. For instance, cotton stalks have a length of 0.83 mm and a diameter of 19.6 μm. [5] 
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Figure 3 - Cellulose fibrillar structure: a) cellulose fibers, b) macrofibers, c) microfibers, and d) 
cellulose chains. [6] 
 
The crystalline structure of cellulose is quite complex because cellulose can exist in different 
polymorphs, specifically cellulose I, II, III and IV. Native cellulose commonly presents the 
cellulose I crystalline structure.[4] Moreover, due to some variations on the hydrogen bonding 
between cellulose chains, different cellulose allomorphs can be observed. For example, 
cellulose I has two allomorphs named Iα and Iβ as represented in Figure 4.  
 
 
Figure 4 - Cellulose allomorphs Iα(left) and Iβ (right), Carbon ● Oxygen ○ and Hyrdrogen ◦ 
atoms.[7] 
 
The degree of polymerization (DP) of cellulose varies in function of its sources, biosynthesis 
process and purification or modification treatments. Typically, native cellulose DP is between 
3000 and 15000: wood cellulose has a DP of about 10000 and cotton cellulose, the most pure 
form of cellulose, of 15000. Purification treatments normally induce a reduction of the degree of 
polymerization.[8] 
This quite complex structure confers to cellulose properties such as hydrophilicity, 
biodegradability, stiffness, and the ability to be chemically modified. [9] 
Bacterial cellulose /poly (N-methacryloyl glycine) prepared by in situ polymerization for biomedical applications  10/56 
2.1 Bacterial cellulose 
Bacterial cellulose (BC) was first identified in 1886 by A. J. Brown. It is produced by bacteria 
in two main steps, namely the synthesis of uridine diphosphoglucose, and then its 
polymerization into β-1-4-glucan chains.[10] 
Among the bacteria capable of producing BC, the gram negative Gluconacetobacter xylinus 
(previously known as Acetobacter xylinum) is recognized as the most effective producer. G. 
xylinus (Figure 5) is a non-pathogenic, rod-shaped bacterium that produces cellulose from 
several carbon and nitrogen sources.[3] 
 
 
Figure 5 - SEM image of Gluconacetobacter xylinus bacteria.[2] 
2.1.1 Bacterial cellulose production 
BC can be produced in both static and agitated cultures. In stationary cultures, BC is obtained as 
an accumulation of a gelatinous membrane on the interface between the air and the culture 
medium[11] (Figure 6, left), whereas in agitated cultures, it is synthesized in a deep medium in 
the form of fibrous suspensions, pellets or irregular masses (Figure 6, right). [12] 
 
  
Figure 6 - BC membrane produced in stationary culture (left) and BC pellets produced in agitated 
culture (right).[2] 
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Bacterial cellulose made from agitated and static cultures presents a similar network structure; 
however, BC produced in agitated culture shows a lower degree of polymerization, crystallinity 
index and Young's modulus.[13] It has been also shown [14] that BC prepared in agitated 
conditions is characterized by a lower Iα mass fraction than cellulose produced statically. A 
decrease of the cellulose fibrils size has also been observed in agitated culture when compared 
to static counterpart. 
Static cultivation allows the control of the shape and size of the BC pellicles and also permits to 
obtain homogeneous membranes.[2] These properties are very well appreciated in the 
biomedical field for instance. However, static cultivations are shaded by high production costs. 
In order to overcome this limitation and improve the productions yields, some reactors have 
been developed. For instance, the horizontal lift reactor [15] and the rotator disk [16] (Figure 7) 
allow a semi-continuous cultivation of BC. The first one give the same properties as statically 
produced BC whereas the rotating one produce a BC capable to retain two times more water 
than BC produced in static conditions. Another reactor called "aerosol bioreactor" [17] can be 
used in order to produce BC in continuous conditions. The production is ensured by a spray of 
glucose at the interface between the culture medium and the air. It leads to homogeneous 
pellicles with enhanced mechanical properties. Creation of several sheets of BC instead of one 
thick membrane is also possible by alternatively stop and start the flux of glucose. 
 
  
Figure 7- Rotary disk reactor [15] (left); Horizontal lift reactor [4] (right). 
 
Agitating culture reactors have also been developed, they allow BC production with higher 
production rates, lower costs and different shapes such as elliptical (air lift modified reactor 
[18]) and spherical (bubble column reactor [2]). For instance, the air lift modified reactors allow 
producing BC with a three time higher rate and the pellets had an average diameter of 10 mm. It 
has been considered that these agitating reactors could be the most suitable for large scale BC 
production.[2]  
Another way to improve the BC production is to choose an appropriate culture medium. The 
most influent parameters of a BC culture medium are the carbon and nitrogen sources. BC is 
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mostly produced using the Hestrin-Schramm (HS) medium that uses glucose as carbon source 
and a combination of peptone and yeast extract as nitrogen sources. [19] 
However, it has been observed that it is possible to enhance BC production by modifying this 
culture medium. Several types of carbon and nitrogen sources have been compared. Among the 
tested carbon sources, one can find several sugars such as glucose, sucrose, maltose, xylose, 
fructose, lactose, and polysaccharides as starch, but also other compounds such as ethanol and 
glycerol. Glycerol and glucose were the most efficient sources.[20] In the same study, several 
nitrogen sources such as peptone, yeast extract, tryptone, and polypeptone beef extract had also 
been compared, in that case yeast extract was the source leading to the higher BC production.  
2.1.2 Bacterial cellulose properties 
First of all, bacterial cellulose has a high degree of polymerization (from 2000 to 8000) [21] and 
a high crystallinity (generally between 60% and 90%).[21] BC is also well known and 
appreciated for its high purity, because in contrary to plant cellulose, BC is free of 
hemicelluloses, pectin and lignin. Furthermore, both plant cellulose and bacterial cellulose are 
biocompatible and biodegradable.[2] 
Secondly, bacterial cellulose is characterized by a particular nano fibrillar network structure 
which confers to it high porosity and water retain capacity.[2] These properties are very useful 
in wound dressing or burn curing for instance.[22], [23] Specifically, BC nanofibers are 
approximately 3-15 nm thick and 70-80 nm width. Those nanofibers are composed of 
protofibers of 2-4 nm diameter gathered to create a ribbon.[2] BC ribbons are arranged in a 
particular 3D network (Figure 8) which is responsible for BC properties. [2], [24] 
  
 
Figure 8 - SEM micrographs of bacterial cellulose surface [25] (left) and cross section [2] (right). 
 
This peculiar nano fibrillar structure together with the high crystallinity provides also very good 
mechanical properties, especially in tension mode. Indeed, the Young's modulus of BC has been 
reported [2] to be equal to 15 GPa, which is very high compared to other typical polymers 
widely used in commercial applications, such as polypropylene (PP) or poly(ethylene 
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terephthalate) (PET). Moreover, BC shows a tensile strength between 200-300 MPa, also 
considerably high when compared to other polymers and in the same range as steel. These 
tensile properties make BC very promising as reinforcing element to improve the mechanical 
resistance of composite materials. 
 
In summary, BC and plant cellulose fibers have the same chemical structure but different 
morphologies and fiber dimensions (Figure 9), and therefore, completely distinct properties, as 
summarized and compared in the Table 1.  
 
 
Figure 9 - Electron micrographs of plant cellulose fibers (left) and bacterial cellulose (right).[26] 
 
Table 1- Comparison of bacterial and plant cellulose fibers properties. 
 
Degree of 
polymerization 
Nanofibers dimensions Tensile strength Young's modulus 
BC [2] 2000-8000 
3-15 nm thickness 
70-80 nm width 
1-20 μm length 
200-300 MPa 15 GPa 
Plant cellulose 3000-15000 [21] 
5-30 μm diameter [5] 
1-25 mm length [5] 
300-500MPa 
[27] 
3-36GPa [27] 
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2.2 Bacterial cellulose applications 
BC peculiar properties have led to various applications in distinct fields, including for example 
the food industry, cosmetics and biomedicine. 
BC is appreciated for its peculiar viscosity and gelatinous aspects. Indeed, BC is the main 
component of the Philippian’s dessert "Nata de Coco" [28] (Figure 10). BC has also been used 
as a food additive in order to modify the texture of the food or to reduce its caloric content.[1], 
[29]  
In the cosmetic industry, BC is used as a component of several commercial products such as, for 
instance, facial scrubs [30] and masks.[31] 
Nevertheless, it is in the biomedical field that BC found most potentialities. For example, BC's 
high mechanical strength coupled with its biocompatibility, in situ moldability and water 
retention capacity inspired the production of artificial BC blood vessels [1], [32] (Figure 10). 
The high mechanical strength allows those vessels to resist to the high blood pressure. 
Additionally, BC has also been explored in the field of tissue engineering and in particular for 
wound and burn treatment (Figure 10).[22] Indeed, its capacity to retain water is really 
appreciated in order to repair the skin after a burn. BC is able to keep the moisture close to the 
wound and also to protect it from the air, facilitating the skin regeneration. 
Last but not least, BC has been investigated as a drug delivery system,[3], [33]–[40] in 
particular for transdermal applications. It has been studied in drug delivery system mostly for its 
porous structure, mechanical properties and its biocompatibility. For example, the use of BC 
membranes for transdermal delivery of several drugs, as lidocaine, ibuprofen, caffeine and 
diclofenac have been reported.  
 
 
Figure 10 - a) Nata de coco; b) BC artificial blood vessel;[32] c) BC as wound healing 
membranes.[16]  
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2.3 BC/polymer nanocomposites 
The potentialities of BC can be extended by combining it with other materials including natural 
or synthetic polymers or even inorganic nanophases (for example, BC/silver nanoparticles [23], 
[41], [42], BC/hydroxyapatite [25], [43]–[46], BC/Fe3O4 [47], BC/Silica [48]). Regarding the 
nanocomposites made with polymers, BC has for instance, been extensively used as reinforcing 
element in nanocomposites for potential applications in numerous fields as electronics and 
biomedicine areas.[3], [9], [49]–[51] There are at least four distinct ways to prepare BC based 
nanocomposites: namely (a) blending BC with the polymeric matrix either by melting-mixing or 
dispersion of BC into the polymer solution followed by drying [52], [53]; (b) modification of 
the bacteria culture medium (addition of the polymer into the culture medium) [54]–[56]; (c) 
incorporation of a polymer solution into BC membranes by diffusion followed by drying [57]–
[60] and, (d) in situ polymerization inside the BC network.[45], [61]–[65] 
In this study, particular attention will be given to BC nanocomposites prepared by in situ 
polymerization. However, some current researches made with each of the above mentioned 
methodologies will be also presented in the next section. 
2.3.1 BC nanocomposites prepared by blending 
Preparing a BC nanocomposite by blending typically involves the previous disintegration and/or 
modification of the BC membrane followed by mixing with the chosen polymeric matrix. The 
blending step can be made either by melting mixing, or by dispersion of BC nanofibrils in a 
polymer solution followed by solvent casting or other drying methodology, as supercritical CO2 
drying. 
Several types of nanocomposites prepared by blending were studied among which one can for 
example find, BC/poly(L-lactic acid),[52] and BC/thermoplastic starch(TPS)[53];  
For example, BC/thermoplastic starch [53] nanocomposites were made using shredded bacterial 
cellulose. BC nanofibers were included into the TPS matrix during the gelatinization process of 
the polymer. As a result, good adhesion between BC and TPS was observed, as well as a good 
dispersion of the fibers into the matrix. Moreover, an enhancement of the thermal properties, 
tensile strength and Young's modulus of the polymer were promoted by the addition of BC 
(Figure 11). However, even if the moisture sorption was reduced by BC, the obtained 
composites appeared to be humidity sensitive. 
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Figure 11 - Young modulus (a) and tensile strength (b) of corn starch thermoplastic composites 
reinforced with 1% and 5% of bacterial and vegetable cellulose.[53]  
 
Another example of BC nanocomposites made by blending are the BC/poly(L-lactic acid) 
(PLA) that were produced by Yuan and co-workers.[52] These composites were made by 
thermal-induced liquid-solid phase separation technology in order to reinforce PLA with BC 
fibers. As a result, the obtained composite had better surface hydrophilicity and thermal 
properties than PLA, and enhanced porosity and mechanical properties compared to that of the 
homopolymer. 
2.3.2 BC nanocomposites made by modifying the culture medium 
The modification of the BC culture medium to produce novel nanocomposites is normally 
achieved by the addition of either soluble or insoluble polymers to the culture medium before 
the inoculation. Therefore, the polymer is incorporated into the BC network during the 
biosynthesis. Normally, this modification of the culture medium doesn't require a special 
processing after BC production; however, typical purification treatments need to be performed. 
Culture modification has been used, for example, to synthesize BC nanocomposites with chitin 
nanocrystals,[54],  poly(ethylene oxide) (PEO),[55] and  poly(vinyl alcohol) (PVA).[56] 
For instance, BC/poly(ethylene oxide) nanocomposites were prepared by adding PEO in the 
culture medium.[55] Different BC/PEO w/w ratios were tested (from 15:85 to 59:41) and it has 
been observed that the higher the ratio the smaller the cellulose nanofibers were. The cellulose 
nanofibers were attached in bundles of 75-770 nm wide and the size of the bundles increase 
with the content of PEO. However, for all tested ratios, the BC nanofibers were homogeneously 
dispersed in the PEO matrix. The crystallinity and melting temperature of the nanocomposites 
were reduced when compared to that of PEO; for the ratio 59:41 the crystallinity went from 
67% for pure PEO to 21% and the melting temperature of PEO decreased 10 degrees (Figure 
12). Results have also shown that the ratio between Iα and Iβ decrease with an increase of the 
BC:PEO ratio and that the preferred crystallization form of BC was Iβ. However, PEO thermal 
stability and tensile properties were increased by the inclusion of BC. 
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Figure 12 - DSC thermograms illustrating the determination of the glass transition and melting 
temperatures in the nanocomposite (left) and the variation in the melting endotherm of PEO as a 
function of the BC/PEO w/w ratio (right).[55]  
 
Another study reported the synthesis of BC/poly(vinyl alcohol) nanocomposites by addition of 
PVA into the bacteria culture medium.[56] PVA was introduced to the HS medium under 
stirring and then incubated at 28 °C. The obtained pellicles were then cross-linked with glyoxal. 
These nanocomposites kept the transparency of PVA, even for the largest amount of BC. 
However, the presence of the cross-linker induced a yellowish coloration to the films. BC 
incorporation in the PVA matrix has led to an increase in the crystallinity of the matrix in the 
nanocomposite; nevertheless, it did not impact its ductility. Finally, the reinforcement of PVA 
with BC led to nanocomposites with excellent mechanical, thermal and dimensional properties, 
as well as moisture stability. This enhancement of the nanocomposites properties is mainly due 
to hydrogen bonding and chemical cross-linking between PVA and BC. 
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2.3.3 BC nanocomposites prepared by diffusion of a polymer solution into the BC membrane 
This methodology consists in introducing a BC membrane into a specific polymer solution 
allowing the polymer solution to migrate into the membrane by diffusion. Afterwards, the 
sample is dried to obtain the nanocomposites. 
This technique has already been used to synthesized BC/poly(ethylene glycol),[57] BC/poly(3-
hydroxybutyrate),[58] and BC/polycaprolactone (PCL) [60] and BC/poly(L-lactic acid) (PLA) 
[59] nanocomposites, among many others. 
 
For instance, BC/poly(L-lactic acid) (PLA) [59] nanocomposites were prepared by introducing 
BC membranes into a PLA solution in chloroform. Optical analysis showed that the 
characteristic transparency of PLA was kept even after the incorporation of BC (Figure 13). In 
addition, BC/PLA nanocomposites showed higher crystallinity than pure PLA and improved 
mechanical properties. 
 
Figure 13 - Light transmittance of (a) bacterial cellulose pellicle, (b) PLLA/bacterial 
cellulose nanocomposite film, and (c) PLLA film.[59]  
2.3.4 BC nanocomposites prepared by in situ polymerization 
The preparation of BC nanocomposites by in situ polymerization involves the introduction of a 
monomer (and initiator and/or cross linker) into the BC membrane, and finally the 
polymerization is subsequently triggered by setting-up appropriated conditions. Different types 
of polymerization approaches can be used, such as conventional free radical polymerization, 
atom transfer radical polymerization (ATRP), reversible addition-fragmentation chain transfer 
(RAFT), among others. For instance, ATRP is a polymerization technique that allows the 
covalent linkage between the polymer and the cellulose chains, while in conventional free 
radical polymerization it could be necessary to use a bi-functional monomer to promote the 
cross linkage of the polymer inside the BC network and consequently prevent its lixiviation 
during processing or washing. 
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Several BC nanocomposites had already been prepared by in situ polymerization using different 
monomers (aniline,[61] styrene,[45] 4-styrene sulfonic acid,[66]  acrylate monomers[62]–[65]) 
and polymerization methodologies. 
For example, conducting BC nanocomposites were prepared by conventional polymerization of 
aniline, in the presence of dodecylbenzenylsulfonic acid (DBSA), into a BC membrane.[61] 
First, a DBSA/aniline solution in ethanol and water was prepared and then, the BC membranes 
were introduced in the solution; afterward the polymerization was carried out at 25 °C during 24 
h. The obtained nanocomposites membranes were washed with ethanol. FTIR and XRD 
analysis were performed and confirmed the polymerization of aniline inside the bacterial 
cellulose network. Moreover, mechanical tests showed that the nanocomposites were more 
brittle than BC alone. However, the results showed that the nanocomposites were conductive 
which confirmed the potentialities of BC as scaffold to create conductive materials. 
In another study, Peng et al. [45] prepared BC/polystyrene (PS) nanocomposites by adding a 
BC membrane into a styrene solution with 1 wt% of azodiisobutyronitrile (AIBN) at room 
temperature during 3 hours. SEM analysis showed that the porous structure of BC was modified 
by the PS incorporation mainly because it filled the pores of the BC membranes. Additionally, 
results showed that the nanocomposites were characterized by a lamellar structure (Figure 14) 
of 300 nm maximum layer thickness and that the mechanical properties of PS were increased by 
the creation of the nanocomposites. However, no signs of strong interaction between the two 
compounds (PS and BC) were observed. 
 
 
Figure 14 - SEM micrographs of the cross section of BC/PS nanocomposites.[45] 
 
In situ polymerization has also been explored to prepare distinct acrylate polymers/BC 
nanocomposites.[62]–[65], Acrylate polymers are widely used because they are very well 
known by chemists and easy to prepare and to tune due to the high availability of different 
acrylate monomers. 
For example, BC/poly(2-hydroxyethyl methacrylate) (PHEMA) nanocomposites films were 
prepared by conventional in situ polymerization using poly(ethylene glycol) diacrylate 
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(PEGDA) as cross-linker.[62] PHEMA appeared to fill the BC membranes in a quite 
homogeneous way (Figure 15) and an increase of the translucence of the materials was 
observed. It has been also shown that the cross-linking prevented the dissolution of the polymer 
during the washing step and consequently, the polymer content in the nanocomposites increased 
with the amount of PEGDA. It was also observed that the 3D structure of BC was not affected 
by the polymerization. The thermal stability and mechanical properties of these nanocomposites 
were enhanced when compared to those of PHEMA due to the excellent compatibility between 
BC and the PHEMA. Finally, a good swelling ratio of 200-260% was obtained and 
biocompatibility tests confirmed that these nanocomposite films were non-cytotoxic and 
allowed the cellular proliferation. 
 
 
Figure 15 – Visual aspects of BC/PHEMA/PEGDA (left) and SEM cross sections images (right)[62]  
 
In addition, BC/poly(glycerol methacrylate) (PGMMA),[63] BC/poly(2-hydroxyethyl 
methacrylate) (PHEMA),[63] BC/poly(2-ethoxyethyl methacrylate) (PEOEMA),[63], [64] 
BC/poly(2-ethylhexyl acrylate) (PEHA),[64] BC/poly(n-vinyl pyrrolidone) (PNVP) [64] 
hydrogels were prepared by Hobzova et al. [63] and Kramer et al. [64] All hydrogels were 
prepared by UV radical polymerization in an aqueous medium after introducing the different 
monomers into the BC membrane. However, for the case of EOEMA and EHA, which are 
hydrophobic, a solvent exchange reaction from water to 2-propanol and ethanol was performed. 
Cross-linkers were used in all cases, and results showed that an almost complete filling of the 
BC membrane by the polymers was attained with the highest concentration of cross-linkers and 
only partial fiber covering was obtained with lower concentrations. All nanocomposites were 
characterized by a good dispersion of the polymers within the BC network and cross linkage 
appeared to reduce swelling capacity of the composites when high concentrations of cross 
linkers were used. Figure 16 shows the aspect of a swelled composite. Regarding the 
mechanical properties, it was observed for all hydrogels an improvement of these properties 
when compared to the neat polymers. 
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Figure 16 - Photograph of BC – poly(HEMA-co-EOEMA) composite in the swollen state.[63]  
 
Finally, in a different study, BC/poly(methyl methacrylate) (PMMA) and BC/poly(n-butyl 
acrylate) (PBA) nanocomposites were produced by ATRP.[65] Firstly, BC membranes were 
functionalized by esterification with 2-bromoisobutyryl bromide (BiBBR) and then methyl 
methacrylate or n-butyl acrylate were polymerized from the BC macro initiator (Figure 17). 
 
Figure 17 - Diagram of the various stages of the polymerization reaction.[65]  
 
The obtained composites had properties depending on the amount of polymer grafted into the 
membranes. Specifically, high grafting led to thermal behaviour similar to the corresponding 
homopolymer while composites with low polymer incorporation had a TGA profile closer to 
that of BC itself. The grafting of the polymer conferred to the nanocomposites a hydrophobic 
character (Figure 18), as well as a decrease of the mechanical properties compared to those of 
BC. 
 
Figure 18 - Contact angle of a water droplet over (a) pristine BC, (b) BC-g-PMMA, and (c) BC-g-
PBA.[65] 
Bacterial cellulose /poly (N-methacryloyl glycine) prepared by in situ polymerization for biomedical applications  22/56 
3. Materials and methods 
3.1 Chemicals  
All chemicals were used as received. 2,2′-Azobis(2-methylpropionamidine) dihydrochloride 
97% (AAPH), used as radical initiator, and N,N'-methylenebisacrylamide 99% (MBA), used as 
cross-linker, were purchased from Sigma-Aldrich. N-methacryloyl glycine 95% (MGly) was 
acquired from Synchem UG & Co. KG (Germany). For the MTT test, the HaCaT cell line was 
obtained from Cell Lines Services (Eppelheim, Germany). The phosphate buffer solution (PBS) 
(pH:7.2) and the Dulbecco′s Modified Eagle′s Medium (DMEM), as well as the fetal bovine 
serum (FBS), L-glutamine, penicillin/streptomycin and fungizone were purchased from Gibco, 
(Life Technologies, (Carlsbad, CA, USA), dimethylsulfoxide (DMSO) (reagent plus ≥ 95%) 
and thiozolyl blue tetrazolium bromide (MTT) were supplied by Sigma-Aldrich. All other 
reagents and solvents were of analytical grade and used as received. 
3.2 BC membranes 
Bacterial nanocellulose (BC) (three-dimensional network of nano- and micro-fibrils with 10–
200 nm width) in the form of wet membranes was produced in our laboratory using the 
Gluconacetobacter sacchari bacterial strain [67] and following established culture procedures. 
[19] In detail, the pre-inocula were prepared by growing the bacteria at 30 °C, during 48 h, in 
static conditions, in HS liquid medium. After this period, the flask was vigorously agitated and 
5 mL of the culture media was withdrawn and inoculated into a 45 mL liquid production 
medium in 250 mL Erlenmeyer flasks. BC membranes were then treated three times with a 0.5 
M NaOH solution, at 80 ºC, for 30 min and washed with distilled water until its whitening and 
reaching pH 7.0. [68] 
3.3 BC_PMGly nanocomposites 
Wet BC 4x4 cm² membranes were weighted and 60% of their water content was removed by 
hand pressing. They were then placed in balloons purged with nitrogen (N2) at 0 ºC during 1 
hour with an aqueous solution of N-methacryloyl glycine, 2,2′-azobis(2-methylpropionamidine) 
dihydrochloride (radical initiator) and N,N'-methylenebisacrylamide (cross-linker). Finally, the 
balloons were left at 70 ºC during 6 hours. The membranes were then washed several times with 
distilled water and leftward in water during one night. Afterwards, they were dried in the oven 
at 40°C during 12 hours. The list of the different samples prepared, as well as their 
compositions is presented in Table 2. 
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Table 2: List of the prepared membranes with their compositions 
Sample WMGly/WBC WMBA/WMGly WAAPH/WMGly 
BC - - - 
BC_PMGly (1:1) 1 5% 1% 
BC_PMGly (1:2) 2 5% 1% 
BC_PMGly (1:3) 3 5% 1% 
BC_PMGly (1:5) 5 5% 1% 
3.4 Drug delivery assays 
Impregnation of diclofenac (DCF) into a BC_PMGly membrane 
Two different membranes of BC_PMGly 1:3 (one with 5% of cross-linker and the other with 
10%) were prepared following the procedure explained in the section 3.2 and kept in wet state; 
in the meantime, a diclofenac solution was prepared by dissolving 80 mg of DCF in 5 mL of 
water. 
After being drained (40%) the membranes were immersed into the diclofenac solution until 
complete absorption of the solution and dried in the oven at 40 °C following the method used by 
Silva et al.[37], and Trovatti et al.[35] and then the release of drug was studied. Table 3 
summarizes the different membranes that were prepared and their compositions.  
 
Table 3: Nanocomposites’ designation and compositions prepared for drug release 
Sample WMGly/WBC WMBA/WMGly WAAPH/WMGly Diclofenac (mg/mL) 
BC _PMGly (1:3:5)_DCF 3 5% 1% 20 
BC_PMGly (1:3:10)_DCF 3 10% 1% 20 
 
Drug release test 
The release of the drug was tested at two different pH values, namely pH 7.4 and 2.1, in order to 
compare the influence of the pH media on the release profile. 
 
Drug release tests at pH 7.4 were performed with a 0.01 M phosphor buffer solution (pH 7.4). 
This solution was prepared by dissolving 8.0 g of NaCl, 0.2 g of KCl, 0.24 g of KH2PO4 and 
3.63 g Na2HPO4.10H2O in 1 L of distilled water. The BC membrane was then placed in 500 mL 
of this solution previously heated at 37 °C. 5 mL aliquots of the solution were removed every 
hour and the absorbance at 276 nm was assessed in order to control the release of the drug.  
Bacterial cellulose /poly (N-methacryloyl glycine) prepared by in situ polymerization for biomedical applications  24/56 
Drug release tests at pH 2.1 were performed by immersing the impregnated nanocomposites 
into an aqueous solution of HCl (pH 2.1) at 37 °C during 24 hours. Again, the release of the 
drug was controlled by measuring the absorbance of the solution every hour. 
3.5 Biomineralization of the nanocomposites 
The biomimetic growth of hydroxyapatite was initiated from simulated body fluid solution and 
adapted from literature data. [25], [44], [46], [69], [70] 
To prepare the SBF solution, 6.5456 g of NaCl were dissolved into 960 mL of water, then 
2.2682 g of NaHCO3, 0.373 g of KCl and 0.1419 g of Na2PO4 were added to the solution, that 
was then heated to 37°C before adding 0.3049 g of MgCl2 x 6H2O, 9 mL of 1M HCl, 0.3675 g 
of CaCl2 x 2H2, 0.071 g of Na2SO4 and 6.057 g of (CH2OH)3CNH2. The pH of the solution was 
then adjusted to 7.4 with 40mL of 1M HCl. The volume of the solution was then fixed to 1000 
mL with distilled water. The solution was kept in the refrigerator. Magnetic stirring was 
maintained during the entire preparation. 
24 hours later, the nanocomposites were immersed into the SBF solution at 37 °C for 7 days. 
The supersaturation conditions were maintained by refreshing the solution every 24hours. The 
resulted nanocomposites were then rinsed with water and dried (half of the sample: freeze dried 
(FD), the other half: oven dried (OD)) before being characterised by SEM and XRD. 
3.6 Nanocomposites characterization 
All the obtained nanocomposites membranes were characterized in terms of structure (FTIR), 
crystallinity (XRD), morphology (SEM), thermal stability (TGA), mechanical properties 
(tensile tests, DMA), swelling behaviour and biological properties (MTT test). 
3.6.1 Fourier Transform Infrared spectroscopy (FTIR) 
FTIR-ATR spectra were taken with a Perkin-Elmer FT-IR System Spectrum BX 
spectrophotometer equipped with a single horizontal Golden Gate ATR cell over the range 600–
4000 cm−1 at a resolution of 2 cm−1 averaged on 32 scans. 
3.6.2 X-Ray Diffraction (XRD) 
XRD analysis were carried out on a PANalytica Empyrean diffractometer using Cu Kα radiation 
(λ=1.541Ǻ). Analysis were made in reflection mode from 5° to 50° (2ϴ) with a step of 0.026° 
and an absolute step rate of 197s. 
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3.6.3 Scanning Electron Microscopy (SEM) 
SEM micrographs of the membranes surface and cross-section were taken with a HR-FESEM 
SU-70 Hitachi equipment operating at 4kV. All samples were coated with evaporated carbon. 
Surface micrographs were obtained with magnification of x10000 and x30000 and cross-section 
micrographs with magnification of x3500 and x15000. 
3.6.4 Thermogravimetric Analysis (TGA) 
TGA assays were carried out with a SETSYS Setaram TGA analyser equipped with a platinum 
cell. The samples were heated from 20 ºC to 800 ºC with a constant rate of 10 ºC min-1 under a 
nitrogen flow of 10 mL min-1. 
3.6.5 Dynamical Mechanical Analysis (DMA) 
DMA was performed with a Tritec 2000 DMA (Triton Technologies) operating in tension 
modes (single strain) at 1 Hz and 0.005 mm displacement. Samples (30 x 5 mm²) were heated 
from -100 ºC to 170 ºC with a constant heating rate of 2 ºC min-1. 
3.6.6 Mechanical tests 
50 x 10 mm² specimens were tested in tension with an Instron 5564 equipment. After being 
dried in the oven, the specimens were put in a desiccator during 48h to assure a homogeneous 
humidity and then tested at room temperature with a rate of 10 mm min-1 using a 1 kN load cell. 
2 membranes were tested for each nanocomposite composition and 3 replicates were analysed 
for each membrane. Elongation at break (%), tensile strength (MPA), and Young’s modulus 
(MPA) were computed with the Bluehill 3 software. 
3.6.7 Swelling ratio (SR) 
The swelling ratios (SR) of the membranes were determined by measuring the weight difference 
between wet and dry states of the membranes using the following equation:  
SR (%) = (Ws – Wd)/Wd x 100; where Ws is the weight of the specimen in the swollen state and 
Wd its initial weight in the dry state. For the measurements, 10x10 mm² specimens were dried, 
and then immersed in distilled water. Weight increase was then regularly registered during 48 
hours. 
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3.6.8 MTT test 
MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) test was performed on 
BC, BC_PMGly 1:1 and BC_PMGly 1:3 in order to assess the cytotoxicity of the membranes. 
The membranes with a BC:monomer ratio of 1:1 and 1:3 were chosen as they are the two 
extreme conditions we have. 
A MTT test is a colorimetric assay that is used to determine the viability of the cell metabolic 
activity. In our case, in order to be closer to the one of the aimed applications (transdermal 
delivery), we have chosen to work with HaCaT skin cells which is a non-tumorigenic 
immortalized human keratinocyte cell line. [71] For the test, the cells were grown in complete 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 10000 U/mL penicillin/streptomycin and 250 µg/mL fungizone at 37 °C in 5% CO2 
humidified atmosphere. Cells were daily observed under an inverted phase-contrast Eclipse 
TS100 microscope (Nikon, Tokyo, Japan). The tests were performed on the two extreme 
nanocomposites: BC_PMGly 1:1 and BC_PMGly 1:3, and to have more accurate results, 3 
samples per nanocomposites were tested. 
 
Biocompatibility assessment was divided into 3 main steps: 
- Preparation of the extract: step during which the membranes are immersed into the chosen 
media to induce the dissolution of every product /compound that could be toxic into the media; 
- Exposure/incubation of the cells: the previous extract is added to the cells, the plates are then 
put in the incubator from 24h to 72h depending on the test conditions.  
- Addition of the MTT reagent and the reading of the plates: the MTT reagent is absorbed by the 
cells, and the ones that are still alive transform the MTT into its insoluble purple formazan 
derivative. By assessing the difference of absorbance between the “control” wells and the wells 
with cells and extract, we are then able to estimate to quantity of cells still alive at the end of the 
test and therefore characterize the cytotoxicity of the samples.  
 
Protocol of the test: 
Samples of 6 cm² area were prepared, rinsed with ultra-pure water and then sterilized in ethanol 
70% during one hour. After that time, they were rinsed again with sterilized PBS to remove the 
ethanol, dissolved in 1.5 mL of medium and incubated at 37 ºC, with 5% CO2 for 24 hours to 
prepare the extract. Due to the powder state of the polymer, its extract was prepared by 
dissolving 100 mg of polymer into 4.5 mL of medium and sterilized by filtration with a 
nanocellulose filter. 
In the meantime, three 96 wells plates were prepared with 5x4 wells filled up with 60000 
cells/well, 50000 cells/well and 30000 cells/well corresponding to a future incubation time of 24 
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h, 48 h, and 72 h. The cells were then incubated during 24 h for adhesion. After that time, the 
extracts obtained from the incubated membranes were removed and 100 μL of it were added to 
each well. The plates were then incubated for 24 h, 48 h, and 72 h.  
At the end of the incubation time, 50 μL of MTT (at a concentration of 1 g L-1) were added in 
each well and incubated for 4 h at 37 ºC in 5% CO2 humidified atmosphere. After that, culture 
medium was removed and 150 μL of dimethyl sulfoxide (DMSO) were added into the wells and 
the plate was placed in a shaker for 2 hours with gentle mixing. Three more wells were filled up 
with DMSO to perform the blank absorbance measurement. The plates were finally read with a 
BioTek Synergy HT plate reader. The absorbance of the wells was measured at 570, 551 and 
842 nm and analysed with Gen5.1 software. Data were analyzed by a two way ANOVA, 
followed by a Holm-Sidak test to evaluate the significant differences between the different 
membranes. 
Bacterial cellulose /poly (N-methacryloyl glycine) prepared by in situ polymerization for biomedical applications  28/56 
4. Results and Discussion 
Different BC nanocomposites membranes were prepared by varying the amount of monomer 
impregnated into the BC membranes in order to determine the influence of the polymer content 
onto the nanocomposites properties. Furthermore, because of the different analyses 
requirements, membranes were also prepared with different sizes and shapes, either 4x4 cm² 
square or 7 cm diameter disc. However, due to the impossibility to perform a film from the 
poly(N-methacryloyl glycine), several analysis such as the tensile test and DMA were not 
performed on the polymer alone. 
The schematic representation of the reaction involved during the free radical polymerization is 
displayed in Figure 19 and the visual aspect of the obtained nanocomposites membranes, in the 
dry and wet states, and of BC is shown in Figure 20. 
One can see that BC, in the dry state, has the appearance of a white film, contrary to the dried 
nanocomposites that appeared as yellowish films. This first change of visual aspect allowed us 
to confirm the polymerization of the N-methacryloyl glycine into the membranes. Additionally, 
the membranes with a BC/monomer ratio of 1:1, 1:2 and 1:3 were quite flexible. However, due 
to a too high amount of polymer and cross linker, the one 1:5 membrane was very brittle and 
therefore, the detailed characterization analyses were not performed for this membrane. On the 
other hand, the wet membranes have the aspect of white swollen gels with good malleability. 
By analysing the visual aspect of the membrane, homogeneity differences could also been 
perceived; indeed, square membranes seemed to be more homogeneous than the disc ones. This 
difference might be due to a better repartition of the monomer into the membranes and a more 
perfect distribution of both membranes’ surfaces in the case of a smaller sample thanks to a 
better fitting into the reaction balloon. Moreover, due to the drying step, some irregularities 
were also observed on the membranes surfaces. In order to improve the homogeneity of the 
membranes, the circular nanocomposites were then prepared in an Erlenmeyer instead of a 
balloon, to induce a better symmetry of the membranes’ surfaces into the reaction medium. 
Finally, the amount of polymer impregnated into the membranes, as well as the yield 
(conversion rate) of the polymerization reaction were determined by assessing the weight 
difference before and after the in situ free radical polymerization and are summarized in Table 
4. The thickness of the membranes, in dry state, were also measured and correlated with the 
amount of acrylate polymer introduced into the membranes. The higher the amount of acrylate 
polymer introduced, the thicker the membranes, nevertheless, one has to keep in mind that this 
thickness, is also influenced by the initial thickness of the BC membrane. 
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Figure 19 - Schematic representation of the MGly free radical polymerization reaction using MBA 
as a cross-linker and AAPH as thermal initiator. 
 
 
Figure 20 - Visual aspects of a) dry BC, b) dry and c) wet nanocomposite (BC_PMGly 1:3).  
 
Table 4: Effective Polymer/BC ratio, polymerization yield, and thickness of the different 
nanocomposites. The thickness was average from 4 different samples per membranes. 
 
BC mass, 
dry state 
(mg) 
MGly 
mass 
(mg) 
Nanocomposites 
mass (mg) 
BC/PMGly 
ratio 
PMGly/MGly 
(%)  
Thickness 
(mm) 
BC_PMGly 1:1 282.17 282.2 352.71 4.0 25% 0.113 
BC_PMGly 1:2 387.00 774.00 511.00 3.1 16% 0.145 
BC_PMGly 1:3 390.64 1117.3 619.40 1.7 19% 0.170 
Bacterial cellulose /poly (N-methacryloyl glycine) prepared by in situ polymerization for biomedical applications  30/56 
4.1 Fourier Transform Infrared spectroscopy (FTIR) 
FTIR analysis was performed in order to confirm the success of the MGly polymerization into 
the BC membranes. Figure 21 displays the FTIR-ATR spectra of pure BC, PMGly and the 
different BC_PMGly nanocomposites prepared in this study.  
On the one hand, the main bands observed in the FTIR spectrum of pure BC are a broad band 
around 3340 cm-1 corresponding to the O-H vibrations; two small bands around 2893 cm-1 
attributed to the stretching vibrations of the CH2 and CH groups; two peaks around 1330 cm-1 
and 1105 cm-1, respectively matching the C-H and C-O vibrations of the C-OH groups; and a 
sharp band around 980-1050 cm-1 assigned to the stretching vibration of C-O-C of the acetal 
linkages of cellulose [66], [72], [73]  
On the other hand, the FTIR spectrum of PMGly is characterized by one band at 3342 cm-1 
assigned to the amine N-H stretching; another one at 2930 cm-1 due to the O-H vibrations, two 
peaks corresponding to the stretching of the C=O moieties at 1715 cm-1 (methacryloyl) and 
1621 cm-1 (glycine), and one peak at 1190 cm-1 corresponding to the vibrations of the C-O 
coming from the C-OH groups of the glycine moieties. 
In addition, while looking at the nanocomposites spectra, one can first observe that they clearly 
correspond to the sum of BC’s and PMGly’s spectra, which corroborate the success of the 
polymerization. Hence, the polymerization was confirmed by the appearance of the specific 
vibrations of PMGly such as: the two bands matching the C=O vibrations at 1715 cm-1 (C=O 
methacryloyl) and 1623 cm-1 (C=O glycine); the band at 1519 cm-1 attributed to the NH 
deformation; and the one at 1191 cm-1 due to the vibrations of the C-O acrylate ester. The NH 
characteristic vibration at 3340 cm-1 can also be observed on the nanocomposites spectra, 
however, one can notice that it appears with a decreased intensity compared to the one on the 
polymer spectrum due to overlap with the OH vibration of bacterial cellulose. The bands at 
2894 cm-1 (C-H stretching), 1300-1400 cm-1 (C-OH) and 1160-1190 cm-1 (C-O stretching) are 
typical of both BC and PMGly. Finally, the results show that the intensity of the characteristic 
peaks of the polymer are increasing with the amount of polymer into the nanocomposite. 
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Figure 21 - FTIR-ATR spectra of native BC, PMGly and BC_PMGly nanocomposites with 
different compositions. 
4.2 X-Ray Diffraction (XRD) 
X-ray diffraction analyses were performed on BC and BC nanocomposites to evaluate the effect 
of the polymerization on the crystallinity of the different membranes. The obtained 
diffractograms are shown in the Figure 22. 
The diffraction pattern of BC, displays the typical reflections of Cellulose I with peaks at 2θ 
equal to 14.8° (101), 16.8° (101), 22.9° (002) and 36.3° (040). [21], [65], [72]  
Conversely, poly(N-methacryloyl glycine) is an amorphous polymer. Indeed, no significant 
crystalline orientation reflections are observed on its diffractogram. It is characterized by a 
broad band centered on 18° typical of amorphous polymers. 
Regarding the different nanocomposites, one can noticed that they all displayed the same 
crystalline pattern, with three main reflections coming from BC semi-crystalline structure at 2θ 
equal to 14.4°, 16.8° and 22.7°; furthermore, the spectra showed a decrease crystallinity 
compared to BC due to introduction of the amorphous polymer into BC’s network. 
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Figure 22 - Diffractograms of pure BC, PMGly, and BC_PMGly nanocomposites. 
4.3 Scanning Electron Microscopy (SEM) 
A selection of SEM micrographs of the surface and cross-section of the different 
nanocomposites membranes and pure BC are shown in Figure 23. Those SEM analyses were 
used to additionally confirm the polymerization reaction, to determine the morphology of the 
nanocomposites and compare the difference in the structure induced by the amount of polymer 
introduced into each membrane. 
The micrographs of pure BC showed the typical 3D network structure of BC revealing 
randomly organised nanofibers (surface images) and a lamellar structure (cross-section 
micrographs). [24], [66], [72] 
The micrographs of the different nanocomposite membranes allowed to observe not only the 
inclusion of the acrylate polymer into the BC 3D network but also the polymer formation on 
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BC’s surface and, therefore, allowed to confirm the success of the polymerization. Moreover, all 
the nanocomposite membranes clearly showed the typical nano- and microstructure of BC, 
which permits to affirm that this was not affected by the polymerization reaction (Figure 23). 
Finally, by the comparison of the different nanocomposites micrographs one can observe that, 
as expected, the lower the ratio BC/monomer, the higher the amount of polymer included into 
the BC membranes. Indeed, this is illustrated on the cross-section micrographs, by more filled 
up lamellar spaces in the case of a ratio 1:3 than 1:1 and on surface micrographs, by an higher 
covering of the 3D network (membranes 1:3) and a more distinct network in the case of the 1:1 
membranes (Figure 23). 
 
Figure 23 - SEM surface and cross-section micrographs of BC (left), BC_PMGly (1:1) (middle) and 
BC_PMGly (1:3) (right). Surface images are on the first two rows with magnifications of x10k and 
x30k and cross-section images are on the last two rows with magnifications of x3.50k and x15k. 
4.4 Thermogravimetric Analysis (TGA) 
Thermogravimetric analysis was used to check the thermal behavior of the nanocomposite 
membranes and of the corresponding individual components.  
Bacterial cellulose /poly (N-methacryloyl glycine) prepared by in situ polymerization for biomedical applications  34/56 
The pure BC membrane displayed a thermogram with a single weight loss profile, typical of 
cellulosic substrates, with an initial decomposition temperature around 270 ºC and a maximum 
decomposition temperature at 348 ºC, corresponding to a weight loss of 47%. 
In comparison, the poly(N-methacryloyl glycine) showed a double step weight loss profile and 
is less thermally stable than BC. Its first decomposition initiated around 170 ºC and reached its 
maximum at 242 ºC (weight loss 15 %) and the main decomposition started around 325 ºC with 
a maximum at 404 ºC and corresponded to a weight loss of 60%. 
All the nanocomposites showed a three step weight loss profile displaying decompositions due 
to both BC and the acrylate polymer. All membranes started to degrade at around 190 ºC and 
reached their first maximum decomposition between 232-242 ºC. The second degradation step 
of the membranes corresponded to the decomposition of BC and began at 253 ºC and 264 ºC 
indicating a diminution of the stability compared to BC. The last observed decomposition step 
was due to the polymer enriched fraction degradation and started around 365 ºC for all the 
membranes. 
Additionally, one can notice an increase of the weight loss associated to the polymer 
degradation with the increasing amount of polymer introduced into the membranes. 
In sum, with a thermal degradation starting at around 190 ºC instead of 170 ºC for the 
homopolymer the membranes can be considered more thermally stable than the PMGly itself. 
This increase in thermal stability can be ascribed to the good compatibility between BC and the 
polymer and the interactions established between them. 
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Figure 24 - Thermograms and the corresponding derivatives of BC, PMGly, and BC_PMGly 
nanocomposites. 
4.5 Dynamic Mechanical Analysis (DMA) 
DMA was performed to investigate the mechanical and viscoelastic properties of the 
nanocomposite membranes. Figure 25 displays the storage modulus (E’) and the tangent δ (tan 
δ) of pure BC and of the different nanocomposites. 
First, as one can perceive that pure BC displayed a storage modulus around 5.1 GPa almost in 
all temperature range, whereas the different membranes seem to have lower storage modulus 
between 1 and 1.5 GPa for the 1:1 and 1:2 membranes, and between 1.5 and 2.5 GPa for the 1:3 
membrane. This reduction in storage capacity compared to pure BC is due to the addition of an 
amorphous polymer into BC’s network. In addition, the membranes appeared to have higher 
storage capacity in the lower range of temperature (-50 ºC  70 ºC). 
Secondly, thanks to the analysis of the evolution of the tan δ in function of the temperature, one 
can notice the absence of glass transition, therefore highlighting the crystallinity of the 
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nanocomposites, already observed in X-Ray analysis. Indeed, as pure BC, all the three 
nanocomposites display a tan δ varying linearly with the temperature and without any evident 
maximum. 
 
 
Figure 25 - Storage modulus and tan δ in function of the temperature of BC and BC 
nanocomposites obtained by DMA analysis in tension mode. The tan δ curves were smoothed with 
Origin.  
4.6 Tensile tests 
Tensile tests were performed for the different obtained nanocomposites and on pure BC to 
characterise the mechanical properties of the membranes and to determine the influence of the 
nanocomposites’ composition on their mechanical properties. Figure 26 summarizes the 
differences in Young’s modulus, tensile strength and elongation at break between all samples 
(BC and BC/PMGly nanocomposites).  
All the studied nanocomposites membranes showed reduced mechanical properties when 
compared to pure BC as revealed by their lower Young’s modulus and tensile stress values. 
This is obviously due to the introduction of an amorphous polymer into the 3D network of BC 
as previously observed for the DMA results. 
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Additionally, by comparing the results from the different nanocomposites, one can notice that 
regarding the Young’s modulus, the lower the amount of polymer the stiffer is the membrane. 
With a Young’s modulus of 4.93 GPa, and a tensile strength of 19.92 MPa the BC_PMGly 1:1 
membrane is the stiffer membrane. In comparison, the BC_PMGly 1:2 and 1:3 have a Young’s 
modulus and a tensile strength of respectively 4.45 GPa and 3.55 GPa, and 10.78 and 11.98 
GPa. Regarding, the elongation at break, one can notice that no significant difference can be 
observed, however, the BC_PMGly 1:1 nanocomposites presented the higher deformation 
before break. 
 
 
Figure 26 - Tensile stress, Young’s modulus and elongation at break comparison in function of the 
sample. a) Comparison between BC and the nanocomposites, b) Comparison only between the 
nanocomposites. 
4.7 Swelling ratio 
The swelling behavior of the nanocomposite membranes was analyzed by measuring their water 
uptake after drying. Figure 27 shows the evolution of the obtained swelling ratios in function of 
time, and Figure 28 displays the FTIR spectrum of one nanocomposite before and after the 
swelling test. 
Several oscillations are clearly perceptible in the swelling graphs. This behavior was attributed 
to the dissolution of the non-reticulated polymer, as in fact confirmed by FTIR (Figure 28). It is 
perceptible a clear decrease of the intensity of the peaks corresponding to the acrylate polymer 
(between 1720 and 1530 cm-1) compared to the intensity of the peaks of BC (around 1000 cm-1). 
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In conclusion, the polymer in the nanocomposites is not cross-linked enough to be retained into 
the membrane in case of a too long immersion into water. Therefore, in this situation it is 
difficult to evaluate this parameter and compare the different samples. 
 
 
Figure 27 - Swelling ratios of BC, and BC_PMGly nanocomposites; Logarithmic fitting was applied 
with Excel. 
 
 
Figure 28 - FTIR spectra of the BC_PMGly 1:3 nanocomposite before and after the swelling tests. 
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4.8 MTT test 
MTT test was performed to assess the cytotoxicity of the nanocomposites. Figure 29 shows the 
preparation of the extract from the nanocomposites membranes. One can notice that the extract 
from BC_PMGly 1:3 appears to have a more reddish color than BC and BC_PMGly 1:1. This 
reddish color is synonym of a more acid medium (the Dulbecco′s Modified Eagle′s Medium, 
DMEM, is usually pink when neutral). In our case, the acidic medium is due to a large amount 
of polymer (with carboxylic acid moieties). 
 
 
Figure 29 - Preparation of the extract, 6 cm² membranes dissolved in DMEM media. 
 
After being incubated for 24 hours, as explained in the experimental section, the three extracts 
coming from each membrane were grouped in conical tubes (Figure 30). Moreover, due to the 
strong concentration of polymer the filtration of the extract was not successful and this one was 
used as obtained after the dissolution of the polymer into the medium. As seen on Figure 30, the 
acidic character of the polymer is characterized by a clear yellow solution. 
 
 
Figure 30 - Visual aspects of the a) PMGly extract, and b) (from left to right) BC, BC-PMGly 1:1, 
BC_PMGly 1:3 extracts. 
 
Figure 31 shows the 96 wells plate filled with the cells and the extract before the incubation and 
the Table 5 displays the schematic representation of each well. 
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Table 5 : Schematic representation of the plate 
M M M M M M M M 
M 
M + 
cells 
cells + BC 
extract 
cells + 1:1 
extract 
cells + 1:3 
extract 
cells + polymer 
extract 
M M 
M 
M + 
cells 
cells + BC 
cells + 1:1 
extract 
cells + 1:3 
extract 
cells + polymer 
extract 
M M 
M 
M + 
cells 
cells + BC 
cells + 1:1 
extract 
cells + 1:3 
extract 
cells + polymer 
extract 
M M 
M 
M + 
cells 
cells + BC 
cells + 1:1 
extract 
cells + 1:3 
extract 
cells + polymer 
extract 
M M 
M M M M M M M M 
With M: media. 
The wells with only the media were filled up in order to prevent the evaporation of the media in 
the wells containing the cells and extracts. 
 
 
Figure 31 - 96 wells plate with the cell and the extract before incubation. 
 
The Figure 32 shows the plate after the incubation during 4 hours with MTT. One can notice a 
purplish color due to the absorption of the MTT by the cell, and its transformation into purple 
formazan by the one that are still alive. 
 
Figure 32 - 96 wells plate after 24 hours incubation and 4 hours incubation with MTT 
 
The cell viability of every specimen was assessed by measuring the absorbance of the solution 
in each well and comparing it with the absorbance of the control one. Figure 33 shows the 
obtained results for the different membranes on the skin viability. 
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Figure 33 – Effects of BC, BC_PMGly 1:1, 1:3 and PMGly on the HaCaT cells for exposure time of 
24h, 48h and 72h. The results are presented as mean +/- standard deviation from 4 different 
specimens per membrane. Symbol * represents significant difference between time of exposure for 
the same membrane (p<0.05). Different letters represent significant differences between one 
membrane and the control, or one membrane and another membrane for each exposure time 
(p<0.05). 
 
First of all, the results showed that the polymer induced almost 100% cell mortality. This is 
certainly due to the high concentration of polymer directly dissolved in the media during the 
preparation of the extract and also due to the impossibility of sterilize this extract; and therefore 
have poor significance. 
Nevertheless, using the two way ANOVA, followed by the Holm-Sidak test, it appears that the 
3 membranes (BC, BC_PMGly 1:1, BC_PMGly 1:3) were not significantly different from the 
control for an exposure time of 24 hours. One can therefore state, that those membranes are non-
cytotoxic to HaCaT after 24 hours of exposition. Additionally, the statistical analysis made on 
the results from 48 hours of exposition revealed that BC, and BC_PMGly 1:3 have cell viability 
of respectively 76% and 72%, whereas the BC_PMGly 1:1 is again considered as non-cytotoxic. 
Moreover, after 72 hours of exposition, BC, BC_PMGly 1:1 and BC_PMGly 1:3 had cell 
viability of respectively 82%, 79% and 68%. 
Finally, the two-way ANOVA test also allowed us to say that the exposure time had no effect 
on the cell viability of BC, but that it had influence on that of the two nanocomposites since for 
both of them, the 72 hours test were significantly different from the 24 hours and the 48 hours. 
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4.9 Drug delivery essays 
Pure BC membranes had been investigated as transdermal drug delivery systems with several 
drug as for example diclofenac and lidocaine. [3], [33], [37], [39] However, for oral delivery it 
is important to tailor the drug release as a function of pH, for example to avoid drug degradation 
at lower pHs. In this line, we decided to test our nanocomposites as drug (diclofenac) delivery 
systems in both acidic and neutral conditions because of their pH sensitivity. 
 
Diclofenac, 2-(2-(2,6-dichlorophenylamino)phenyl)acetic acid (DCF), which chemical structure 
is shown in the Figure 34, is a non-steroidal anti-inflammatory drug. It is mainly used to relief 
moderate suffering such as headache, osteoarthritis, rheumatoid arthritis or short term clinical 
operations, by reducing the substances that causes pain and inflammation. [37], [74] 
 
Figure 34 - Diclofenac chemical structure. 
 
We have chosen to work on diclofenac in order to be able to compare its release from our new 
nanocomposites and its release from pure BC membrane. [37] 
 
Impregnation of the drug 
First, it can be observed in the Figure 35 that after the drug impregnation, the obtained dried 
membrane is whiter than the original nanocomposite, confirming the absorption of the drug by 
the membrane. 
 
 
Figure 35 - Visual aspect of the dried BC_PMGly1:3_DCF membrane after the impregnation of the 
drug. 
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Figure 36 compares the FTIR spectrum of both nanocomposites before and after impregnation 
and diclofenac alone. 
The FTIR spectrum of diclofenac displays several typical absorption peaks, specifically at 3390 
cm−1 (N-H stretching), 3030 and 3079 cm-1 (=C-H aromatics), 1572 cm−1 (COO anti-
symmetrical vibration), 1603 cm−1 (C=C ring skeletal vibration), 1350–1250cm−1 (C-N 
stretching), and 710–745 cm-1 (C-H out of plane, di- and tri- substituted rings). [37] 
Therefore, the impregnation of the drug can be further confirmed by the appearance of the 
typical DCF peaks on the spectrum of the impregnated nanocomposite. Indeed, one can easily 
distinct on this spectrum the three sharp peaks at 714, 744 and 764 cm-1 corresponding to the out 
of plane vibration from the C-H of the aromatic rings and the two peaks at 1280 and 1303 cm-1 
matching the stretching of the C-N bonds of diclofenac molecules. However, due to overlapping 
or interactions established between diclofenac and the nanocomposites (as suggested by the 
spectra of the mixture of the PMGly and diclofenac, PMGly + DCF), some peaks have been 
shifted. It is the case for example for the 1715 cm-1 (C=O) peak of PMGly that is shifted to 1684 
cm-1 and the one at 1621 cm-1 which moved to 1601 cm-1. Nevertheless, this behaviour must be 
investigated in more detail. 
 
Figure 36 - FTIR-ATR spectra of BC, PMGly, DCF and BC_PMGly1:3_DCF. 
 
Drug release test 
The diclofenac release from the nanocomposite membranes was tested at pH 7.4 and 2.1 during 
24 hours at 37 °C for two different membranes prepared with different amounts of cross-linker 
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(MBA), namely 5% and 10% (compared to the amount of monomer) because of the results 
obtained for the swelling tests. To assess the drug release, the absorbance’s of the solutions 
were assessed every hour. Their evolution in function of time are displayed in the Figure 37 and 
the FTIR-ATR spectrum of the different nanocomposites before and after the test are shown in 
Figure 38. 
 
After observing in the swelling test that part of the polymer can be dissolved from the 
nanocomposite, we decided to investigate by FTIR this dissolution after the release test. The 
results, with both amount of cross linker, showed the disappearance of the polymer from the 
membranes in the case of pH 7.4. Indeed, no typical peaks such as the PMGly/DCF peaks 
around 1689 cm-1 or the DCF typical ones around 764 cm-1 are presents on the spectrum. In the 
case of pH 2.1, the FTIR spectrum obtained from the nanocomposites are more similar to the 
one of the initial membrane, nevertheless, the reduce intensity of the polymer peaks compared 
to that of BC suggest a reduction of the polymer amount into the nanocomposite membrane. 
Moreover, it has also been confirmed that the polymer absorbed at 276 nm, therefore, it is 
impossible to link the absorbance of the solution to the drug concentration in the solution. 
However, we can conclude that the higher absorbance obtained at pH 7.4 suggest a higher 
dissolution of polymer and diclofenac in neutral conditions than in acidic pH. 
In sum, a new way to perform the diclofenac release has to be found, in order to prevent the 
dissolution of the polymer. This could be done with even higher amounts of cross-linker. 
 
 
Figure 37 - Comparison of the absorbance evolution in function of time at pH 7.4 and 2.1 for the 
BC _PMGly (1:3)_DCF and BC_PMGly (1:3:10)_DCF nanocomposites; fitting was computed with 
Excel. 
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Figure 38 - FTIR-ATR spectra of BC and BC_PMGly1:3_DCF before and after release test at 
different pH (7.4 and 2.1) with different amount of cross linker (5% and 10%) 
4.10 Biomineralization of the nanocomposites 
Bones are mainly composed of hydroxyapatite (HAp) nanocrystals and collagen. HAp is well 
known for its great osteoconductivity and bioactivity, whereas collagen is known for its 
susceptibility to mutation. [75] Therefore, even if HAp/collagen nanocomposites have been 
studied, [76]–[80] efforts have been made in order to find a material that could overcome 
collagen’s issues and BC/HAp and polymeric/HAp nanocomposites have been synthesised and 
characterised. [25], [43], [46], [69], [81] BC has been chosen for its peculiar porosity, 
mechanical properties, biocompatibility and biodegradability. In that direction, our objective 
was to initiate biomimetic apatite formation on our membranes, in order to create a new porous 
HAp_BC_PMGly nanocomposite with enhanced properties. 
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Two nanocomposites membranes (both of them were BC_PMGly nanocomposite with a 
BC:monomer ratio of 1:2 however, one of them was freeze dried after polymerization and the 
other one was kept in wet state) were biomineralized following the methods described in the 
section 3.5. After the biomineralization, half of each membrane was freeze dried and the other 
half oven dried at 40 °C. At the end, four different nanocomposites were obtained. Table 6 
summarizes the different chosen designation of the samples in function of the applied treatment. 
The growth of any minerals was controlled by XRD and SEM. 
 
Table 6: Designation of the different biomineralized samples 
 
After polymerization After biomineralization 
Freeze dried Kept in wet state Freeze dried Oven dried 
BC_PMGly 1:2 WOD  X  X 
BC_PMGly 1:2 WFD  X X  
BC_PMGly 1:2 FDOV X   X 
BC_PMGly 1:2 FDFD X   X 
4.10.1 X-ray diffraction 
X-ray diffractograms of the obtained nanocomposites are shown in Figure 39. The typical 
diffractions of BC are not very intense in these diffractograms due to the appearance of two 
intense peaks at 32.1°, 45.8°. These peaks were attributed to NaCl in its cubic form for all the 
samples using the software High Score version 4.1, suggesting that the formation of 
hydroxyapatite did not occur in considerable extension.  
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Figure 39 - XRD diffractograms of the different biomineralized nanocomposites. 
4.10.2 Scanning electron microscopy 
The surfaces of the obtained nanocomposites were then analyzed by SEM in order to check the 
formation of NaCl and, therefore, confirm the results obtained by XRD. Some micrographs at 
magnification of x10k and x30k are shown in the Figure 40 and Figure 41. Additionally, the 
elements found by EDX analysis are listed with their estimated amount in the Table 7, while a 
typical EDX spectrum is shown in Figure 42. 
The formation of mineral particles, indicated by XRD, was confirmed in SEM by the 
observation of some spherical and cubic shape inorganic particles on the surface of BC fibers 
(Figure 40 and Figure 41). In the same way, the EDX results confirmed the higher abundance of 
chlorine and sodium in all the different nanocomposites corroborating the growth of NaCl. 
However, the very small or inexistent amount of phosphate and calcium found by EDX again 
suggest that the hydroxyapatite hasn’t grown in significant amount. These experiments need to 
be repeated and improved aiming to avoid the formation of NaCl that certainly the HAp growth. 
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Figure 40 - SEM pictures of a) BC-PMGly 1-2_FDFD, b) BC_PMGly 1:2_FDOD, c) BC_PMGly 
1:2_WFD, d) BC_PMGly 1:2 WOD at a magnification of x10k 
 
 
Figure 41 - SEM pictures of a) BC-PMGly 1-2_FDFD, b) BC_PMGly 1:2_FDOD, c) BC_PMGly 
1:2_WFD, d) BC_PMGly 1:2 WOD at a magnification of x30k 
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Table 7: List of the different elements and their concentrations found in the nanocomposites, the 
concentrations are given in wt%. The 2 main compounds (besides carbon and oxygen) of the 
samples are highlighted in grey. 
 Na Cl Ca K Mg P 
BC_PMGly 1:2 WOD 2.4% 8.0% 1.3% 0.7% 0.5% 0.4% 
BC_PMGly 1:2 WFD 7.8% 22.7% 1.4% - 0.7% 0.1% 
BC_PMGly 1:2 FDOD 1.2% 6% 3.7% 0.8% 1.4% 1.3% 
BC_PMGly 1:2 FDFD 11.7% 20.4% 0.5% 0.3% 0.2% 0.1% 
 
 
Figure 42 – Typical EDX spectrum obtained with the BC-PMGly 1:2_FDFD nanocomposite 
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5. Conclusions 
In this study, we were able to create novel nanocomposites through the in situ free radical 
polymerization of N-methacryloyl glycine into the three dimensional network of bacterial 
cellulose using N,N'-methylenebisacrylamide as cross-linker. 
This embedment of the polymer into BC resulted into an increase of the mechanical and thermal 
properties of the polymer confirming reinforcement ability of BC. Moreover, due to the 
amorphous character of the polymer, the obtained nanocomposites had reduced crystallinity and 
mechanical properties when compared to BC. 
By analysing the influence of the polymer content we can say that increasing amounts of 
polymer induced a higher filling of the pores of BC resulting in higher nanocomposite 
thicknesses. However, the increase of the polymer content had no significant impact on the 
thermal stability of the nanocomposites.  
In addition, the polymer incorporation into BC successfully produced non-cytotoxic materials 
up to 48 hours of exposure regarding to skin cells and with more than 70% of cell viability for 
72 hours of exposure. It was also observed that the increase of the amount of polymer caused a 
decrease of the cell viability regarding HaCaT skin cell after more than 24 hours of exposure.  
From all nanocomposite prepared, BC_PMGly 1:1 is the one with the highest cell viability, 
mechanical resistance and crystallinity. 
In terms of the potential applications, we have successfully impregnated diclofenac into our 
nanocomposites membranes and were able to release the drug with a controlled behaviour at 
both pH 7.4 and 2.1. However, we have noticed the dissolution of the polymer during the 
release tests. In addition, the biomineralization of the nanocomposites from a simulated body 
solution did not led to the growth of hydroxyapatite particles on our membranes. Indeed, XRD 
and SEM analysis have confirmed the growth of NaCl particles, possibly due to water 
contamination in the lab. 
In the future, further analyses will be made to complete the characterisation of the 
nanocomposites; for instance, solid state NMR will be performed on the different membranes 
and the effect of the polymer introduction on the cell adhesion will be studied by SEM. 
Additionally, the diclofenac release will be tested with higher amounts of cross-linker, and high-
performance liquid chromatography (HPLC) will be used to characterize better the previous 
releases. Regarding the biomineralization, tests will be repeated with pure water to assess the 
contamination of the sample by NaCl before the reaction and in case of an effective HAp 
growth, compressive test will be performed on the membranes. Finally, a new potential 
application of the nanocomposite in the field of water purification will also be investigated. 
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